Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 10 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 9598454

    Mannose derivatives for treating bacterial infections

    Vertex Pharmaceuticals Incorporated · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted

  2. US 9592232

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted

  3. US 9550761

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted

  4. US 9522145

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Dec 20, 2016 · Expires Dec 15, 2036

    granted

  5. US 9518056

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted

  6. US 9511067

    Substituted spiro[piperidine-4,1'-pyrrolo[1,2-a]pyrazine]s as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted

  7. US 9504683

    Heteroaryl derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted

  8. US 9499497

    Compounds useful as inhibitors of indoleamine 2,3-dioxygenase

    Vertex Pharmaceuticals Incorporated · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted

  9. US 9487555

    Prodrug of an ice inhibitor

    Vertex Pharmaceuticals Incorporated · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted

  10. US 9464102

    Prodrugs of pyridone amides useful as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted

  11. US 9434717

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted

  12. US 9422271

    Pyrimidine compounds as tuberculosis inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted

  13. US 9421196

    Amides as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted

  14. US 9403839

    Pyran-spirocyclic piperidine amides as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

  15. US 9399648

    Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis

    Vertex Pharmaceuticals Incorporated · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted

  16. US 9393235

    Pyridone amides as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  17. US 9394302

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted

  18. US 9376448

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted

  19. US 9371287

    Process for making modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted

  20. US 9365557

    Substituted pyrazin-2-amines as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted

  21. US 9365588

    Benzoxazines as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted

  22. US 9359380

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted

  23. US 9351962

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted May 31, 2016 · Expires May 26, 2036

    granted

  24. US 9345708

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted May 24, 2016 · Expires May 19, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.